Biotech/Biomedical
News Category
Earth Science Tech’s Vertical Integration Drives 8% Revenue Growth in Fiscal 2026
Earth Science Tech Inc. (ETST) reported an 8% revenue increase for fiscal 2026, driven by its vertically integrated healthcare model connecting teleme...
Lexaria Announces Reverse Stock Split to Regain Nasdaq Compliance
Lexaria Bioscience Corp. will effect a 1-for-15 reverse stock split on August 3, 2026, to increase its share price and meet Nasdaq's minimum bid price...
Dr. Lee Newcomer, Author of UNMASKED, Signs With Creative Management Partners for Book and Media Representation
Dr. Lee Newcomer, a former chief medical officer of UnitedHealthcare and author of UNMASKED, has signed with agent Alan Morell of Creative Management ...
Novel Vitamin B12 Treatment Offers Hope in Glioblastoma Multiforme
A new preclinical study reveals that an experimental therapy containing vitamin B12 could halt the progression of glioblastoma multiforme, the deadlie...
VolitionRx Highlights Growing Clinical Evidence Supporting Nu.Q NETs Test for Sepsis and NETosis-Related Diseases
VolitionRx announces that multiple peer-reviewed studies support its Nu.Q H3.1 test as a biomarker for sepsis, capable of distinguishing it from non-i...
HeartBeam to Discuss Q2 Results and Strategy for Global ECG Platform Adoption
HeartBeam will host a conference call on August 13 to review its second-quarter financial results and outline strategy for accelerating global adoptio...
Instinct Bio and INVITRX Partner to Bring GENREVER to U.S. and Boost Regenerative Medicine in Indonesia
Instinct Bio announced a strategic collaboration with INVITRX to manufacture and sell GENREVER cosmetic products in the U.S. and support regenerative ...
Renaissance BioScience Appoints Dr. James Tansey to Board of Directors
Renaissance BioScience Corp. appoints Dr. James Tansey, a seasoned entrepreneur and academic, to its board, bringing expertise in technology commercia...
Alexandre B. de Moura, MD, and Timothy T. Roberts, MD, Named 2026 Castle Connolly Top Doctors
Two orthopaedic spine surgeons from New York Spine Institute have been recognized as Castle Connolly Top Doctors, a distinction awarded to only 7% of ...
BRAIN Biotech AG Names Dr. Sven K. Weber as New CEO, Succeeding Adriaan Moelker
Dr. Sven K. Weber will become CEO of BRAIN Biotech AG on October 1, 2026, bringing extensive experience in the industrial enzyme business from BASF, a...
ZEAL Network SE Invites to Earnings Call for Half-Year Report 2026
ZEAL Network SE announces its earnings call for the half-year report 2026, providing investors and analysts with insights into the company's financial...
Regentis Biomaterials Targets $3 Billion Cartilage Repair Market with Cell-Free Gelrin C
Regentis Biomaterials is advancing Gelrin C, a cell-free hydrogel for knee cartilage repair, aiming to address a $3 billion U.S. market and reduce the...
VERAXA Biotech Expands Patent Portfolio to Protect Next-Generation Cancer Therapy Platforms
VERAXA Biotech has expanded its intellectual property portfolio with new patent filings covering its BiTAC-TCE and BiTAC-ADC platforms, strengthening ...
MindBio Therapeutics Delivers First Edge AI Kiosk Prototypes for Rapid Impairment Screening in Workplace Safety
MindBio Therapeutics has completed and delivered its first Edge AI Intoxication and Fatigue Detection Kiosk prototypes, using voice analysis with over...
NeuroThera Labs Validates Quantum Sampling Workflow for Clinical Data Analytics on S&P 500 Company's Platform
NeuroThera Labs has internally validated a proprietary quantum sampling workflow that enables continuous clinical data to be represented and analyzed ...
American Fusion Begins Texatron Fusion Engine Testing at Texas Tech
American Fusion Inc. has initiated the Texatron Fusion Engine testing program at Texas Tech University, marking a key step toward validating its modul...
Datavault AI Expands DataMEDS Licensing Agreement Into Commercial Healthcare
Datavault AI expands its licensing agreement with DataMeds AI to extend blockchain technology into commercial healthcare, enabling patient-controlled ...
Fed Vote Tally May Offer More Insight Than Rate Decision
The article argues that the distribution of votes among FOMC members is a more informative metric than the final rate decision for investors and compa...
VERAXA Biotech Appoints Dr. Christoph Erkel as Chief Scientific Officer to Advance BiTAC(R) Cancer Therapy Platform
VERAXA Biotech strengthens its scientific leadership with Dr. Christoph Erkel as CSO, signaling progress for its BiTAC(R) platform and oncology pipeli...
VERAXA Biotech Expands Patent Portfolio to Strengthen Next-Generation Cancer Therapy Platforms
VERAXA Biotech AG announced the expansion of its intellectual property portfolio with new patent filings, bringing its total to over 50 granted patent...
American Fusion Expands Commercial Leadership as Texatron Development Advances Through Testing and Patent Milestones
American Fusion Inc. appointed Alec Rossa as Chief Revenue Officer to lead commercialization of its fusion technology, with progress in testing, regul...
Nearly 23 Million U.S. Adults May Be Newly Eligible for Blood Pressure Medication Under 2025 Guideline
A new study in the Journal of the American Heart Association finds that nearly 1 in 3 U.S. adults with high blood pressure may need medication under u...
Dr. Edward H. Davidson Named 2026 Castle Connolly Top Doctor for Plastic Surgery Expertise
Dr. Edward H. Davidson, a board-certified plastic surgeon at Palm Beach Plastic Surgery Institute, has been named a 2026 Castle Connolly Top Doctor, r...
Greenland Mines Secures Canadian Patent for Klotho Gene Therapy Technology, Advancing Neurological Treatments
Greenland Mines (GRML) obtained a Canadian patent for Klotho-based gene therapies targeting cognition and neurodegenerative diseases, expanding its IP...
Quantum BioPharma Outlines Lucid-MS Development and Commercial Growth Strategy
Quantum BioPharma's executive discusses the company's strategy for advancing Lucid-MS into Phase 2 trials and the commercial potential of unbuzzd, hig...
VERAXA Biotech Shareholders Overwhelmingly Approve Governance and Financing Measures
VERAXA Biotech shareholders approved corporate governance and financing measures with over 99.94% support, enabling greater flexibility for acquisitio...
NowMedia Television Networks and Dr. Nathan S. Bryan Launch 'Your Optimal Health' Program
The new television series 'Your Optimal Health' aims to provide science-based health information and practical strategies for improving health, perfor...
Regentis Biomaterials Builds Commercial and Regulatory Momentum as GelrinC Advances Toward Key Milestones
Regentis Biomaterials' GelrinC cartilage regeneration platform is progressing toward pivotal clinical and regulatory milestones, with strategic indust...
Greenland Mines Secures Canadian Patent for Klotho Gene Therapy Targeting Neurodegenerative Diseases
Greenland Mines Ltd. announced a Canadian patent for its Klotho-based gene therapy technology, protecting intellectual property for treatments targeti...
Standardized Functional Safety Language Gains Traction with TSMC Involvement
The push for a common language in functional safety, backed by TSMC, aims to streamline semiconductor design for safety-critical applications across i...
Silver Strengthens on Geopolitical Uncertainty and Shift in Investor Sentiment
Silver prices rose as geopolitical tensions drove investors toward precious metals, with implications for mining companies like Collective Mining Ltd.
Autoantibodies May Hold Key to Understanding Cancer Risk Variability
Researchers plan to investigate the role of autoantibodies in cancer risk and immune response, which could explain why some individuals develop cancer...
Gaxos.ai Inc. Outlines Post-Divestiture Strategy Focused on AI and Health Businesses
Gaxos.ai Inc. announced its post-divestiture strategy to expand AI applications and health offerings after selling gaming assets, reporting significan...
NextPlat Corp. Reports Mid-Year Progress Toward Profitability with Record Gross Margins
NextPlat Corp. announced improved financial performance, record consolidated gross margins of 35%, and strategic expansion in healthcare and e-commerc...
NanoViricides Awaits Regulatory Decision on Ebola Trial for NV-387 Oral Gummies
NanoViricides is awaiting regulatory approval in the DRC to begin a Phase II trial of its NV-387 Oral Gummies for the Bundibugyo ebolavirus, which cur...
Lantern Pharma's LP-184 Cleared by EMA for Bladder Cancer Trial in Europe
Lantern Pharma received EMA clearance for an investigator-initiated Phase 1b/2 trial of LP-184 in advanced or metastatic bladder cancer, advancing its...
Nightfood Holdings Featured in AINewsWire Editorial on Connected Robotics
Nightfood Holdings (NGTF), operating as TechForce Robotics, was highlighted in an AINewsWire editorial for its Robotic Connective Network technology t...
Earth Science Tech Builds Vertically Integrated Healthcare Platform for Dilution-Free Growth
Earth Science Tech Inc. leverages its compounding pharmacy and telemedicine subsidiaries to create a synergistic healthcare platform that reduces liab...
LataMed AI Partners with Caracas Schools to Launch Telemedicine Services for Families and Staff
LataMed AI Corp. has signed agreements with two Caracas schools to develop school-based telemedicine programs, potentially expanding healthcare access...
NeuroOne Highlights Potential Paradigm Shift for Epilepsy Patients Treated with OneRF Brain Ablation System Based on Physician Reports
Physicians at Mayo Clinic report that NeuroOne's OneRF Ablation System, used with its SEEG electrodes, enables bedside ablation of seizure foci with r...
From Brooklyn Family Roots to America's Retail Giants: Mitch Gould's Three-Decade Journey
Mitch Gould's career evolution from family-taught distribution principles to creating the Evolution of Distribution® model has enabled brands to enter...
David Ferrera Urges Medical Device Industry to Prioritize Translational Discipline Over Breakthrough Inventions
CEO David Ferrera argues that medical device innovation fails less due to weak science and more due to neglecting practical workflow, urging a focus o...
Renaissance BioScience Receives Genome BC Funding to Develop RNAi Biopesticide for Soil-Dwelling Wireworms
Renaissance BioScience Corp. has secured Genome BC funding to extend its yeast-based RNAi biopesticide platform to target soil-dwelling crop pests lik...
Flow Cytometry Diagnostics Market to Reach $3.5 Billion by 2036 Driven by MRD Testing and Multiparametric Analysis
The global flow cytometry diagnostics market is projected to grow from $1.5 billion in 2026 to $3.5 billion by 2036 at 8.9% CAGR, driven by rising dem...
High-Pressure Glass Autoclaves Market Set to Reach USD 355 Million by 2036, Driven by R&D Investment and Visual Reaction Monitoring
The global high-pressure glass autoclaves market is projected to grow from USD 162 million in 2026 to USD 355 million by 2036 at 8.2% CAGR, fueled by ...
GeoVax Reports Second Quarter 2026 Financial Results and Advances GEO-MVA Toward Pivotal Study
GeoVax provides business update highlighting progress toward initiating a pivotal immunobridging study for its GEO-MVA vaccine under an expedited regu...
VERAXA Biotech Advances Bispecific ADC Program Under OmniAb Collaboration
VERAXA Biotech's bispecific ADC program VXA-222 hits a key milestone under its OmniAb collaboration, advancing to the next phase of development for pr...
Quantum BioPharma Executive Outlines Lucid-MS Development Strategy and Commercial Growth Plans
Quantum BioPharma's executive discusses the company's strategy for advancing Lucid-MS, a multiple sclerosis drug candidate, and its commercial product...